453 related articles for article (PubMed ID: 27744334)
1. Shape matters: the complex relationship between aggregation and toxicity in protein-misfolding diseases.
Ries HM; Nussbaum-Krammer C
Essays Biochem; 2016 Oct; 60(2):181-190. PubMed ID: 27744334
[TBL] [Abstract][Full Text] [Related]
2. The spread of prion-like proteins by lysosomes and tunneling nanotubes: Implications for neurodegenerative diseases.
Victoria GS; Zurzolo C
J Cell Biol; 2017 Sep; 216(9):2633-2644. PubMed ID: 28724527
[TBL] [Abstract][Full Text] [Related]
3. Protein Misfolding Diseases.
Hartl FU
Annu Rev Biochem; 2017 Jun; 86():21-26. PubMed ID: 28441058
[TBL] [Abstract][Full Text] [Related]
4. Prions and the potential transmissibility of protein misfolding diseases.
Kraus A; Groveman BR; Caughey B
Annu Rev Microbiol; 2013; 67():543-64. PubMed ID: 23808331
[TBL] [Abstract][Full Text] [Related]
5. Prion-Like Protein Aggregates and Type 2 Diabetes.
Mukherjee A; Soto C
Cold Spring Harb Perspect Med; 2017 May; 7(5):. PubMed ID: 28159831
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Pairs of Toxic and Nontoxic Misfolded Protein Oligomers Elucidates the Structural Determinants of Oligomer Toxicity in Protein Misfolding Diseases.
Limbocker R; Cremades N; Cascella R; Tessier PM; Vendruscolo M; Chiti F
Acc Chem Res; 2023 Jun; 56(12):1395-1405. PubMed ID: 37071750
[TBL] [Abstract][Full Text] [Related]
7. From Seeds to Fibrils and Back: Fragmentation as an Overlooked Step in the Propagation of Prions and Prion-Like Proteins.
Marrero-Winkens C; Sankaran C; Schätzl HM
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32927676
[TBL] [Abstract][Full Text] [Related]
8. Animal models for prion-like diseases.
Fernández-Borges N; Eraña H; Venegas V; Elezgarai SR; Harrathi C; Castilla J
Virus Res; 2015 Sep; 207():5-24. PubMed ID: 25907990
[TBL] [Abstract][Full Text] [Related]
9. Prion-like features of misfolded Aβ and tau aggregates.
Morales R; Callegari K; Soto C
Virus Res; 2015 Sep; 207():106-12. PubMed ID: 25575736
[TBL] [Abstract][Full Text] [Related]
10. Mechanistic Insights into the Role of Molecular Chaperones in Protein Misfolding Diseases: From Molecular Recognition to Amyloid Disassembly.
Hervás R; Oroz J
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276458
[TBL] [Abstract][Full Text] [Related]
11. Pathogenic mechanisms of prion protein, amyloid-β and α-synuclein misfolding: the prion concept and neurotoxicity of protein oligomers.
Ugalde CL; Finkelstein DI; Lawson VA; Hill AF
J Neurochem; 2016 Oct; 139(2):162-180. PubMed ID: 27529376
[TBL] [Abstract][Full Text] [Related]
12. Misfolded protein aggregates: mechanisms, structures and potential for disease transmission.
Moreno-Gonzalez I; Soto C
Semin Cell Dev Biol; 2011 Jul; 22(5):482-7. PubMed ID: 21571086
[TBL] [Abstract][Full Text] [Related]
13. Recent progress in prion and prion-like protein aggregation.
Yi CW; Xu WC; Chen J; Liang Y
Acta Biochim Biophys Sin (Shanghai); 2013 Jun; 45(6):520-6. PubMed ID: 23709368
[TBL] [Abstract][Full Text] [Related]
14. Type 2 diabetes as a protein misfolding disease.
Mukherjee A; Morales-Scheihing D; Butler PC; Soto C
Trends Mol Med; 2015 Jul; 21(7):439-49. PubMed ID: 25998900
[TBL] [Abstract][Full Text] [Related]
15. Underlying mechanisms and chemical/biochemical therapeutic approaches to ameliorate protein misfolding neurodegenerative diseases.
Hekmatimoghaddam S; Zare-Khormizi MR; Pourrajab F
Biofactors; 2017 Nov; 43(6):737-759. PubMed ID: 26899445
[TBL] [Abstract][Full Text] [Related]
16. Camelid single-domain antibody fragments: Uses and prospects to investigate protein misfolding and aggregation, and to treat diseases associated with these phenomena.
Pain C; Dumont J; Dumoulin M
Biochimie; 2015 Apr; 111():82-106. PubMed ID: 25656912
[TBL] [Abstract][Full Text] [Related]
17. Review: membrane-associated misfolded protein propagation in natural transmissible spongiform encephalopathies (TSEs), synthetic prion diseases and Alzheimer's disease.
Jeffrey M
Neuropathol Appl Neurobiol; 2013 Apr; 39(3):196-216. PubMed ID: 23171056
[TBL] [Abstract][Full Text] [Related]
18. Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases.
Cheng B; Gong H; Xiao H; Petersen RB; Zheng L; Huang K
Biochim Biophys Acta; 2013 Oct; 1830(10):4860-71. PubMed ID: 23820032
[TBL] [Abstract][Full Text] [Related]
19. [Can prion-like propagation occur in neurodegenerative diseases?: in view of transmissible systemic amyloidosis].
Yoshida K; Higuchi K; Ikeda S
Brain Nerve; 2012 Jun; 64(6):665-74. PubMed ID: 22647474
[TBL] [Abstract][Full Text] [Related]
20. Proteomic analysis of protein homeostasis and aggregation.
Laskowska E; Kuczyńska-Wiśnik D; Lipińska B
J Proteomics; 2019 Apr; 198():98-112. PubMed ID: 30529741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]